China, Sept. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development and validation of a prognostic prediction model for breast cancer based on quantitative assessment of intratumoral heterogeneity using DCE-MRI'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133469
Registration Time: 2026/09/28
Type: Observational study
Primary Sponsor: Fuzhou University Affiliated Provincial Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=325652
Published by HT Digital Content Services with permission from Health Daily Digest....